JPWO2023061508A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023061508A5
JPWO2023061508A5 JP2023501526A JP2023501526A JPWO2023061508A5 JP WO2023061508 A5 JPWO2023061508 A5 JP WO2023061508A5 JP 2023501526 A JP2023501526 A JP 2023501526A JP 2023501526 A JP2023501526 A JP 2023501526A JP WO2023061508 A5 JPWO2023061508 A5 JP WO2023061508A5
Authority
JP
Japan
Prior art keywords
cup
antistatic agent
atomization
atomizing
cup according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023501526A
Other languages
Japanese (ja)
Other versions
JP2023549995A (en
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/130338 external-priority patent/WO2023061508A1/en
Publication of JP2023549995A publication Critical patent/JP2023549995A/en
Publication of JPWO2023061508A5 publication Critical patent/JPWO2023061508A5/ja
Pending legal-status Critical Current

Links

Claims (14)

霧化カップであって、
カップ本体とカップ蓋を含み、前記カップ本体はプラスチック材質であり、前記カップ本体には帯電防止剤が添加されていることを特徴とする霧化カップ。 An atomizing cup,
An atomizing cup comprising a cup body and a cup lid, wherein the cup body is made of plastic material, and an antistatic agent is added to the cup body. 前記カップ本体に添加される帯電防止剤の含有量が０．０３質量％～１０質量％、好ましくは０．０５～５質量％であることを特徴とする請求項１に記載の霧化カップ。 The atomizing cup according to claim 1, characterized in that the content of the antistatic agent added to the cup body is 0.03% to 10% by weight, preferably 0.05 to 5% by weight. 前記カップ本体の材質は、ポリプロピレン（ＰＰ）、ポリ乳酸（ＰＬＡ）、ポリエチレン（ＰＥ）、ポリ塩化ビニル（ＰＶＣ）、ポリスチレン（ＰＳ）、ポリカーボネート（ＰＣ）から選択される透明プラスチックであることを特徴とする請求項１に記載の霧化カップ。 The material of the cup body is a transparent plastic selected from polypropylene (PP), polylactic acid (PLA), polyethylene (PE), polyvinyl chloride (PVC), polystyrene (PS), and polycarbonate (PC). The atomizing cup according to claim 1. 前記カップ蓋の材質は、ポリプロピレン（ＰＰ）、ポリ乳酸（ＰＬＡ）、ポリエチレン（ＰＥ）、ポリ塩化ビニル（ＰＶＣ）、ポリスチレン（ＰＳ）、ポリカーボネート（ＰＣ）から選択されるプラスチックであることを特徴とする請求項１に記載の霧化カップ。 The material of the cup lid is a plastic selected from polypropylene (PP), polylactic acid (PLA), polyethylene (PE), polyvinyl chloride (PVC), polystyrene (PS), and polycarbonate (PC). The atomizing cup according to claim 1. 前記カップ蓋には帯電防止剤が添加されており、前記カップ蓋に添加される帯電防止剤の含有量が０．０３質量％～１０質量％、好ましくは０．０５～５質量％であることを特徴とする請求項１に記載の霧化カップ。 An antistatic agent is added to the cup lid, and the content of the antistatic agent added to the cup lid is 0.03% to 10% by mass, preferably 0.05 to 5% by mass. The atomization cup according to claim 1, characterized in that: 前記カップ蓋にはミスト吸入口及び吸引ノズルが開けられることを特徴とする請求項１に記載の霧化カップ。 The atomizing cup according to claim 1, wherein the cup lid is provided with a mist inlet and a suction nozzle. 前記帯電防止剤はアニオン型帯電防止剤、両性イオン型帯電防止剤、ノニオン型帯電防止剤及び高分子型帯電防止剤から選択される１種又は２種以上の組み合わせであることを特徴とする請求項１～６のいずれか１項に記載の霧化カップ。 A claim characterized in that the antistatic agent is one or a combination of two or more selected from anionic antistatic agents, amphoteric antistatic agents, nonionic antistatic agents, and polymeric antistatic agents. The atomizing cup according to any one of items 1 to 6. 前記アニオン型帯電防止剤は、アルキルスルホン酸塩類、リン酸アルキル類、無水マレイン酸と他の単量体との共重合体塩類、ポリアクリル酸塩及びポリスチレンスルホン酸塩から選択される１種又は２種以上の組み合わせであり、前記両性イオン型帯電防止剤は両性アルキルイミダゾリン塩及び／又はアルキルアミノ酸であり、前記ノニオン型帯電防止剤は脂肪酸多価アルコールエステル及び／又はポリオキシエチレン付加物であり、前記高分子型帯電防止剤はポリオキシエチレン脂肪エーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリエチレングリコール脂肪酸エステル及びポリアクリル酸誘導体から選択される１種又は２種以上の組み合わせであることを特徴とする請求項７に記載の霧化カップ。 The anionic antistatic agent is one selected from alkyl sulfonates, alkyl phosphates, copolymer salts of maleic anhydride and other monomers, polyacrylates, and polystyrene sulfonates, or It is a combination of two or more types, and the amphoteric ionic antistatic agent is an amphoteric alkylimidazoline salt and/or an alkyl amino acid, and the nonionic antistatic agent is a fatty acid polyhydric alcohol ester and/or a polyoxyethylene adduct. , the polymeric antistatic agent is one or a combination of two or more selected from polyoxyethylene fatty ether, polyoxyethylene alkyl phenyl ether, polyethylene glycol fatty acid ester, and polyacrylic acid derivative. Atomization cup according to claim 7. 前記ノニオン型帯電防止剤は脂肪アルコールポリオキシエチレンエーテル、アルキルフェノールポリオキシエチレンエーテル及びグリセリンモノ脂肪酸エステルから選択される１種又は２種以上の組み合わせであり、前記両性イオン型帯電防止剤はアルキルジカルボキシメチルアンモニウムエチルラクトン及び／又はドデシルジメチルベタインであり、前記高分子型帯電防止剤はエチレンジアミンのエチレンオキシドプロピレンオキサイド加成物、ポリ４－ビニルピリジン型ポリ石鹸、オクチルスチレン及びスチレンスルホン酸共重合型ポリ石鹸から選択される１種又は２種以上の組み合わせであることを特徴とする請求項８に記載の霧化カップ。 The nonionic antistatic agent is one or a combination of two or more selected from fatty alcohol polyoxyethylene ether, alkylphenol polyoxyethylene ether, and glycerin monofatty acid ester, and the amphoteric ionic antistatic agent is alkyl dicarboxylate. Methyl ammonium ethyl lactone and/or dodecyl dimethyl betaine, and the polymer type antistatic agent is an ethylene oxide propylene oxide adduct of ethylene diamine, poly 4-vinyl pyridine type poly soap, octyl styrene and styrene sulfonic acid copolymer type poly soap. The atomizing cup according to claim 8, wherein the atomizing cup is one type or a combination of two or more types selected from the following. 前記霧化カップの容積が３００～８００ｍｌ、好ましくは５００ｍｌであることを特徴とする請求項１に記載の霧化カップ。 Atomization cup according to claim 1, characterized in that the volume of the atomization cup is between 300 and 800 ml, preferably 500 ml. 請求項１～６のいずれか１項に記載の霧化カップの製造方法であって、
カップ本体の製造原料に帯電防止剤成分又は帯電防止マスターバッチを添加するステップを含むことを特徴とする製造方法。 A method for manufacturing an atomization cup according to any one of claims 1 to 6 , comprising:
A manufacturing method comprising the step of adding an antistatic agent component or an antistatic masterbatch to raw materials for manufacturing a cup body. 霧化吸入投与装置の製造における請求項１～６のいずれか１項に記載の霧化カップの使用。 Use of an atomization cup according to any one of claims 1 to 6 in the manufacture of an atomization inhalation administration device. 前記使用は、呼吸器系疾患を予防及び／又は治療するための薬物の霧化吸入投与装置の製造における前記霧化カップの使用であることを特徴とする請求項１２に記載の使用。 13. Use according to claim 12, characterized in that the use is of the atomization cup in the manufacture of an atomization inhalation administration device for drugs for the prevention and/or treatment of respiratory diseases. 前記薬物はワクチンであることを特徴とする請求項１３に記載の使用。 Use according to claim 13, characterized in that the drug is a vaccine.
JP2023501526A 2021-11-29 2022-11-07 Atomization cup and its use in atomization inhalation administration Pending JP2023549995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202111429885.3 2021-11-29
CN202111429885 2021-11-29
PCT/CN2022/130338 WO2023061508A1 (en) 2021-11-29 2022-11-07 Nebulizer cup and use thereof in nebulization inhalation administration

Publications (2)

Publication Number Publication Date
JP2023549995A JP2023549995A (en) 2023-11-30
JPWO2023061508A5 true JPWO2023061508A5 (en) 2024-03-11

Family

ID=85988145

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023501526A Pending JP2023549995A (en) 2021-11-29 2022-11-07 Atomization cup and its use in atomization inhalation administration
JP2023001322U Active JP3244837U (en) 2021-11-29 2023-04-19 Atomization cup and its use in atomization inhalation administration

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023001322U Active JP3244837U (en) 2021-11-29 2023-04-19 Atomization cup and its use in atomization inhalation administration

Country Status (4)

Country Link
EP (1) EP4442302A1 (en)
JP (2) JP2023549995A (en)
CN (1) CN116173358A (en)
WO (1) WO2023061508A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118059356A (en) * 2022-11-24 2024-05-24 康希诺生物股份公司 Aerosol inhalation bag and application thereof in aerosol inhalation administration

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011817A1 (en) * 1991-12-16 1993-06-24 The University Of Melbourne Improvements in the administration of aerosol compounds
DE59409856D1 (en) * 1994-05-19 2001-10-11 Pari Gmbh Device for drying and buffering aerosols
US6981660B2 (en) * 2000-09-25 2006-01-03 Evit Labs Shock wave aerosolization apparatus and method
US20030205226A1 (en) * 2002-05-02 2003-11-06 Pre Holding, Inc. Aerosol medication inhalation system
CN101053685A (en) * 2006-04-10 2007-10-17 陈清甫 Portable atomized medicine introducing device
JP2013523377A (en) * 2010-04-13 2013-06-17 ビルギチ，マフムト Mouthpiece button of dry powder inhaler
CN202198932U (en) * 2011-08-12 2012-04-25 李卫东 Simple medicine atomizer
GB201115154D0 (en) * 2011-09-01 2011-10-19 Clement Clarke Int Ltd Spacer
US9364622B2 (en) * 2012-04-20 2016-06-14 Fsc Laboratories, Inc. Inhalation devices and systems and methods including the same
GB201321717D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN203829437U (en) * 2014-05-13 2014-09-17 成都维信电子科大新技术有限公司 Efficient inhalation spacer enabling breathing to be smoother
CN110013588B (en) * 2019-04-10 2022-02-22 杭州飞羊生物科技有限公司 High-performance mesh screen type atomizer
CN211383232U (en) * 2019-11-20 2020-09-01 韦小慧 Portable children's atomizer
CN213789374U (en) * 2020-09-01 2021-07-27 北京吉纳高新医疗器械有限公司 Cylindrical antistatic drug feeder
CN213609064U (en) * 2020-09-23 2021-07-06 深圳市新鸿镁医疗器械有限公司 Atomized liquid medicine cup
CN113546255A (en) * 2021-07-28 2021-10-26 深圳来福士雾化医学有限公司 Vaccine atomizing device
CN113517062B (en) * 2021-09-14 2021-12-10 青岛未来移动医疗科技有限公司 Intelligent vaccine atomization system and use method

Similar Documents

Publication Publication Date Title
CA2480273C (en) Ph-sensitive polymer
CA2512738C (en) Method for producing an oral pharmaceutical form with immediate disintegration and active ingredient release
JP6242998B2 (en) Ophthalmic aqueous composition
IL274106B2 (en) Composition for treating hyperlipidemia comprising oxyntomodulin derivative
CZ286411B6 (en) Thermoplastic material
SK105995A3 (en) Coating and binding agents for drug forms
TWI639510B (en) Polyvinyl alcohol film
CA2591972C (en) Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release
JPH0220564A (en) Novel polymer composition
ATE399538T1 (en) MATRIX PREPARATIONS FOR THE CONTROLLED PRESENTATION OF MEDICINAL MEDICINAL PRODUCTS
BR112012001466A2 (en) counterfeit-resistant dosage form for oxidation-sensitive opioids, their manufacturing process, and packaging
NO160901B (en) PROCEDURE TE FOR PREPARING A PHARMACEUTICAL P IN THE FORM OF A POLYACRYLATE FILM.
WO2011064111A1 (en) Film-like pharmaceutical dosage forms
AU2013232038A1 (en) Injectable ibuprofen formulation
JPWO2023061508A5 (en)
Bonepally et al. Preparation, characterisation and in vivo evaluation of silybin nanoparticles for the treatment of liver fibrosis
JPH021710A (en) Polymer containing amino group, its preparation, and its use
JPS6133006B2 (en)
WO2001094440A2 (en) Method of and items containing polyhydroxyalkanoate for reducing latex exposure
US20160346289A1 (en) Fixed-Dose Combinations of Antiviral Compounds
JP3244837U (en) Atomization cup and its use in atomization inhalation administration
Kasashima et al. Oral sustained release of a hydrophilic drug using the lauryl sulfate salt/complex
JP5846716B2 (en) Ophthalmic composition for soft contact lenses
GB2285989A (en) Aqueous formulations for enteric coatings
WO2024109930A1 (en) Atomization inhalation bag and use thereof in atomization inhalation administration